{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-015139","form_type":"8-K","ticker":"ENSC","cik":"0001716947","company_name":"Ensysce Biosciences, Inc.","filed_at":"2026-04-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.797494+00:00","generated_at":"2026-05-15T07:38:18.828720+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"confidence":"high","headline":"Director Curtis Rosebraugh resigns from Ensysce Biosciences board","bullets":["Resignation effective April 1, 2026; no reason given in notice.","Rosebraugh served on the Nominating and Corporate Governance Committee until resignation.","Resignation notice filed as Exhibit 17 to the 8-K.","No replacement announced at this time."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-015139","json":"https://secwatch.observer/filing/0001493152-26-015139.json","markdown":"https://secwatch.observer/filing/0001493152-26-015139.md","text":"https://secwatch.observer/filing/0001493152-26-015139.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716947/000149315226015139/0001493152-26-015139-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716947/000149315226015139/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T07:38:18.828720+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}